Rhythm Pharmaceuticals (RYTM)
(Delayed Data from NSDQ)
$38.11 USD
-0.34 (-0.88%)
Updated Apr 18, 2024 04:00 PM ET
After-Market: $38.11 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth F Momentum F VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 33% (82 out of 251)Zacks Sector Rank
Top 13% (2 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.11 | 1.35 | 9.99 |
Current Quarter Estimate | -2.12 | 7.43 | 60.00 |
Year Ago Quarter Estimate | -0.92 | 0.12 | 52.54 |
Next Quarter Estimate | -0.64 | 7.81 | 61.00 |
Next Year Estimate | -1.97 | 37.76 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -26.56 | 13.10 | 17.08 |
Next Year | 51.36 | 7.60 | 8.00 |
Last 5 Years | -317.20 | 1.00 | 8.10 |
Next 5 Years | 53.50 | 20.40 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -2.18 |
Price/Book (MRQ) | 13.39 | 2.22 |
Price/Cash Flow (MRFY) | NA | 15.70 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -238.50% | -100.99% |
Return on Equity (TTM) | -96.02% | -55.59% |
Debt to Equity (MRQ) | NA | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.